Anastasios Gianakakos - Net Worth and Insider Trading
Anastasios Gianakakos Net Worth
The estimated net worth of Anastasios Gianakakos is at least $141 Million dollars as of 2024-08-24. Anastasios Gianakakos is the President and CEO of MyoKardia Inc and owns about 624,790 shares of MyoKardia Inc (MYOK) stock worth over $141 Million. Details can be seen in Anastasios Gianakakos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anastasios Gianakakos has not made any transactions after 2020-07-02 and currently still holds the listed stock(s).
Transaction Summary of Anastasios Gianakakos
Anastasios Gianakakos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anastasios Gianakakos owns 2 companies in total, including MyoKardia Inc (MYOK) , and LianBio (LIANY) .
Click here to see the complete history of Anastasios Gianakakos’s form 4 insider trades.
Insider Ownership Summary of Anastasios Gianakakos
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MYOK | MyoKardia Inc | 2020-07-02 | director & President and CEO |
LIANY | LianBio | 2021-10-29 | director |
Anastasios Gianakakos Latest Holdings Summary
Anastasios Gianakakos currently owns a total of 1 stock. Anastasios Gianakakos owns 624,790 shares of MyoKardia Inc (MYOK) as of July 2, 2020, with a value of $141 Million.
Latest Holdings of Anastasios Gianakakos
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MYOK | MyoKardia Inc | 2020-07-02 | 624,790 | 224.91 | 140,521,519 |
Holding Weightings of Anastasios Gianakakos
Anastasios Gianakakos Form 4 Trading Tracker
According to the SEC Form 4 filings, Anastasios Gianakakos has made a total of 18 transactions in MyoKardia Inc (MYOK) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in MyoKardia Inc is the sale of 5,000 shares on July 2, 2020, which brought Anastasios Gianakakos around $469,900.
Insider Trading History of Anastasios Gianakakos
- 1
Anastasios Gianakakos Trading Performance
GuruFocus tracks the stock performance after each of Anastasios Gianakakos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anastasios Gianakakos is 21.1%. GuruFocus also compares Anastasios Gianakakos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anastasios Gianakakos within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anastasios Gianakakos's insider trading performs compared to the benchmark.
Performance of Anastasios Gianakakos
Anastasios Gianakakos Ownership Network
Ownership Network List of Anastasios Gianakakos
Ownership Network Relation of Anastasios Gianakakos
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Anastasios Gianakakos Owned Company Details
What does MyoKardia Inc do?
Who are the key executives at MyoKardia Inc?
Anastasios Gianakakos is the director & President and CEO of MyoKardia Inc. Other key executives at MyoKardia Inc include General Counsel Denelle J Waynick , Chief Business Officer Jake Bauer , and Chief Financial Officer Taylor C. Harris .
MyoKardia Inc (MYOK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
MyoKardia Inc Insider Transactions
Anastasios Gianakakos Mailing Address
Above is the net worth, insider trading, and ownership report for Anastasios Gianakakos. You might contact Anastasios Gianakakos via mailing address: 333 Allerton Ave., South San Francisco Ca 94080.